IRIS - Res&Arch Institutional Research Information System - Research & Archive

CANDELORO, Paola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 323
EU - Europa 235
AS - Asia 87
Totale 645
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 323
IT - Italia 71
IE - Irlanda 51
CN - Cina 37
UA - Ucraina 26
SE - Svezia 24
HK - Hong Kong 22
SG - Singapore 22
FI - Finlandia 13
RU - Federazione Russa 12
GB - Regno Unito 11
DE - Germania 9
BE - Belgio 7
CZ - Repubblica Ceca 3
CH - Svizzera 2
IN - India 2
RO - Romania 2
UZ - Uzbekistan 2
AT - Austria 1
FR - Francia 1
KR - Corea 1
LU - Lussemburgo 1
PL - Polonia 1
TR - Turchia 1
Totale 645
Salva come PNG Salva come JPEG
Città #
Chandler 88
Dublin 51
Perugia 44
Ann Arbor 41
San Mateo 28
Hong Kong 22
Wilmington 18
Altamura 16
Singapore 16
Beijing 14
Jacksonville 14
Medford 14
Princeton 14
Lawrence 12
Brussels 7
Redmond 6
Woodbridge 6
Falls Church 4
Saint Petersburg 4
Andover 3
Des Moines 3
Helsinki 3
Los Angeles 3
Olomouc 3
Amelia 2
Boardman 2
Bucu 2
Hyderabad 2
Redwood City 2
San Paolo di Civitate 2
Ashburn 1
Frankfurt Am Main 1
Hanover 1
Houston 1
Izmir 1
Mountain View 1
Napoli 1
Norwalk 1
Nürnberg 1
Seoul 1
Terni 1
Totale 457
Salva come PNG Salva come JPEG
Nome #
Different brain responses to hypoglycemia induced by equipotent doses of long-acting insulin analog detemir and human regular insulin in humans 113
Portal vein glucose sensors do not play a major role in modulating physiological responses to insulin-induced hypoglycemia in humans. 73
Short-term effects of the long-acting insulin analog detemir and human insulin on plasma levels of insulin-like growth factor-I and its binding proteins in humans. 63
Pharmacokinetics and pharmacodynamic of therapeutic dose of basel insulins NPH, Glargine and Detemir after one week of daily administration at bedtime in Type 2 daibates: a randomized, cross-over study. 48
Pharmacokinetics and pharmacodynamics of insulin glargine given in the evening as compared with in the morning in type 2 diabetes 48
Hyperglycemia, Both Chronic and in Short-Term Peaks, Results in Rapid Increase of Expression of Monocyte Inducible Cyclooxygenase (COX-2) in Subjects with T2DM 42
Low levels of unmodified insulin glargine in plasma of people with type 2 diabetes requiring high doses of basal insulin 39
Pharmacokinetics, pharmacodynamics, and modulation of hepatic glucose production with insulin glargine U300 and glargine U100 at steady state with individualized clinical doses in type 1 diabetes 39
Greater Suppression of Glucagon, Lipolysis, and Ketogenesis with Insulin Glargine U300 as Compared with Glargine U100 in Type 1 Diabetes Mellitus 39
PHARMACOKINETIC AND PHARMACODYNAMIC HEAD-TO-HEAD COMPARISON OF CLINICAL, EQUIVALENT DOSES OF INSULIN GLARGINE 300 U/ML AND INSULIN DEGLUDEC 100 U/ML IN TYPE 1 DIABETES 38
Metabolism of insulin glargine after repeated daily subcutaneous injections in subjects with type 2 diabetes. 37
Glargine metabolism over 24 h following its subcutaneous injection in patients with type 2 diabetes mellitus: A dose–response study 36
Pharmacokinetics and pharmacodynamics of NPH insulin in type 1 diabetes: The Importance of appropriate resuspension before subcutaneous injection 36
Different insulin concentrations in resuspended vs. unsuspended NPH insulin: Practical aspects of subcutaneous injection in patients with diabetes. 28
Totale 679
Salva come PNG Salva come JPEG
Categoria #
all - tutte 2.859
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.859
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202050 1 3 3 1 5 5 4 3 4 13 5 3
2020/2021103 1 7 3 4 39 5 9 10 11 3 7 4
2021/2022128 2 19 0 5 7 4 2 35 4 9 27 14
2022/2023234 15 45 7 27 20 28 0 8 74 0 7 3
2023/202494 6 8 5 1 2 0 18 0 4 3 34 13
Totale 679